Roth Capital Upgrades IGI Laboratories (IG) to Buy; Sees 2016 at Break-Out Year
Tweet Send to a Friend
Roth Capital upgraded IGI Laboratories (NYSE: IG) from Neutral to Buy with a price target of $11.00 (from $7.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
